Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Norflex — NORFLEX
Application NDA012157 (NDA)
Norflex — DISIPAL
Application NDA010653 (NDA)
Medihaler Ergotamine — MEDIHALER ERGOTAMINE
Application NDA012102 (NDA)
Tenuate — TENUATE
Application NDA017669 (NDA)
Tenuate — TENUATE DOSPAN
Application NDA012546 (NDA)
Tenuate — TEPANIL TEN-TAB
Application NDA017956 (NDA)
Tenuate — TENUATE
Application NDA011722 (NDA)
Tenuate — TENUATE
Application NDA017668 (NDA)
Tenuate — TEPANIL
Application NDA011673 (NDA)
Septisol — SEPTISOL
Application NDA017424 (NDA)
Septisol — TURGEX
Application NDA018375 (NDA)
Septisol — HEXA-GERM
Application NDA017411 (NDA)
Septisol — PHISOHEX
Application NDA006882 (NDA)
Septisol — PHISOHEX
Application NDA008402 (NDA)
Septisol — SOY-DOME
Application NDA017405 (NDA)
Septisol — GAMOPHEN
Application NDA006270 (NDA)
Septisol — DIAL
Application NDA017421 (NDA)
Septisol — GERMA-MEDICA
Application NDA017412 (NDA)
Septisol — SEPTI-SOFT
Application NDA017460 (NDA)
Septisol — TURGEX
Application NDA019055 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)